Clearmind Medicine (NASDAQ:CMND) Releases Earnings Results

Clearmind Medicine (NASDAQ:CMND) posted its quarterly earnings data on Thursday. The company reported ($0.16) EPS for the quarter, Zacks reports.

Clearmind Medicine Stock Up 0.3%

Shares of Clearmind Medicine stock opened at $0.86 on Friday. The stock’s fifty day moving average is $0.97 and its 200-day moving average is $1.19. The firm has a market capitalization of $3.66 million, a PE ratio of -0.46 and a beta of 0.91. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.01. Clearmind Medicine has a 12-month low of $0.80 and a 12-month high of $2.30.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.